Life Through The Nose: FDA Approves Nasal Spray Narcan

The timeline for availability and price of this OTC product is determined by the manufacturer. The FDA will work with all stakeholders to help facilitate the continued availability of naloxone nasal spray products during the time needed to implement the Narcan switch from prescription to OTC status, which may take months. Other formulations and dosages of naloxone will remain available by prescription only. Drug overdose persists as a major public health issue in the United States, with more than 101,750 reported fatal overdoses occurring in the 12-month period ending in October 2022, primarily driven by synthetic opioids like illicit fentanyl. <a href="https://four4thefire.medium.com/life-through-the-nose-fda-approves-nasal-spray-narcan-8ed14a222477">Read More</a>